Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
The possibility of a Bitcoin crash raises significant questions about its impact on investors and the broader cryptocurrency ecosystem. While experts agree that such an event...
